|
|
中西医结合治疗难治性胃食管反流的机制与效果研究
|
Abstract:
目的:探讨中西医结合治疗难治性胃食管反流(rGERD)的作用机制及临床效果,为rGERD临床治疗提供依据。方法:选取2023年1月至2024年1月我院86例rGERD患者,随机分为对照组与观察组各43例。对照组予常规西医治疗(雷贝拉唑 + 多潘立酮),观察组加用中医辨证治疗(肝胃不和证用柴胡疏肝散加减,脾胃湿热证用清中汤加减),均治疗8周。比较两组疗效、症状评分、食管黏膜愈合率及不良反应。结果:观察组总有效率93.02%,高于对照组74.42% (P < 0.05)。治疗后观察组胃灼热、反酸、胸骨后疼痛评分及总评分均低于对照组(P < 0.05);食管黏膜愈合率86.05%,高于对照组65.12% (P < 0.05);两组不良反应发生率(9.30% vs 13.95%)无差异(P > 0.05)。结论:中西医结合治疗rGERD疗效确切,可改善症状、促进黏膜愈合且安全,其机制与调节胃肠动力、抑酸护膜、改善炎症相关。
Objective: To investigate the mechanism and clinical efficacy of integrated traditional Chinese and Western medicine (TCM-WM) in treating refractory gastroesophageal reflux disease (rGERD), and to provide evidence for its clinical management. Methods: A total of 86 rGERD patients admitted to our hospital from January 2023 to January 2024 were selected and randomly divided into a control group (n = 43) and an observation group (n = 43). The control group received conventional Western medicine treatment (rabeprazole + domperidone), while the observation group received additional TCM syndrome differentiation treatment: Chaihu Shugan San modified for liver-stomach disharmony syndrome, or Qingzhong Tang modified for spleen-stomach damp-heat syndrome. Both groups were treated for 8 weeks. The efficacy, symptom scores, esophageal mucosal healing rate, and adverse reactions were compared between the two groups. Results: The total effective rate in the observation group was 93.02%, significantly higher than 74.42% in the control group (P < 0.05). After treatment, the scores for heartburn, acid reflux, retrosternal pain, and the total symptom score in the observation group were all lower than those in the control group (P < 0.05). The esophageal mucosal healing rate in the observation group was 86.05%, higher than 65.12% in the control group (P < 0.05). There was no significant difference in the incidence of adverse reactions between the two groups (9.30% vs. 13.95%, P > 0.05). Conclusion: Integrated TCM-WM therapy is effective for rGERD, improving symptoms, promoting mucosal healing, and demonstrating safety. The mechanism is related to regulating gastrointestinal motility, inhibiting acid and protecting the mucosa, and improving inflammation.
| [1] | 赵吉鑫. 胃食管反流病消化内科中西医结合治疗的临床分析[J]. 内蒙古中医药, 2025, 44(4): 48-50. |
| [2] | 刘静怡, 韩冰, 刘希桐, 王棚, 陈乾, 李鲜. 胃食管反流病中西医发病机制及药物治疗研究进展[J]. 时珍国医国药, 2024, 35(3): 701-705. |
| [3] | 梁宇晗, 何慧彬, 郑敏, 赵琰, 王石红. 中西医结合治疗难治性反流性食管炎的临床疗效及对脑肠肽指标的影响[J]. 中国中西医结合消化杂志, 2023, 31(6): 456-462. |
| [4] | 袁潇. 中西医结合治疗难治性胃食管反流病(RGERD)的临床疗效分析[D]: [硕士学位论文]. 昆明: 云南中医药大学, 2023. |
| [5] | 张泰, 张北华, 马祥雪, 王凤云, 唐旭东. 中西医结合治疗难治性胃食管反流病的优势[J]. 中国中西医结合杂志, 2022, 42(9): 1124-1131. |